FDA Consent Decree & DOJ Injunction Legal Defense
Navigating Federal Injunctions, Enforcement Defense, and Operational Continuity
Facing an FDA consent decree or DOJ injunction can threaten your company’s operations, financial stability, and future. Our regulatory counsel helps you respond strategically, negotiate workable compliance obligations, and navigate enforcement proceedings while pursuing opportunities to preserve critical business activities and address FDA concerns effectively.
Strategic Defense for Consent Decrees & DOJ Injunctions
Over the past 16 years, we have represented companies facing the FDA's most severe enforcement actions, including federal injunctions and Consent Decrees negotiated alongside the Department of Justice (DOJ).
A Consent Decree is not just a legal penalty; it is a strict, court-ordered operational overhaul that can paralyze a business if not negotiated carefully. We work directly with executive teams, technical experts, and federal prosecutors to negotiate the scope of the decree, ensuring that compliance milestones are realistic and that the company can maintain critical operations where possible.
In recent matters, we have guided manufacturers through the rigorous third-party audit requirements mandated by a decree, systematically correcting systemic quality failures to build a defensible track record and eventually petition the FDA to lift the injunction.
Key Provisions and Negotiation Strategies in DOJ Injunctions





Managing Third-Party Audits and cGMP Remediation

Consent decrees may require independent experts to evaluate manufacturing practices, identify compliance gaps, and report findings directly to FDA. We help clarify audit scope, expert qualifications, and submission deadlines so your team understands its obligations under the court order.
Our counsel works alongside quality assurance consultants to structure corrective and preventive action (CAPA) plans addressing identified deficiencies and decree requirements. Each corrective measure should include documented implementation and verification of effectiveness. Organized audit reports, validation records, and training documentation help demonstrate measurable progress to FDA investigators.
Restarting restricted operations requires satisfying the decree’s conditions and obtaining written FDA authorization when required. We coordinate with the responsible FDA offices, including the Office of Inspections and Investigations, formerly ORA, during reinspection and compliance review. Continued audits, timely reporting, and effective quality controls support sustained compliance and help reduce exposure to liquidated damages.
How We Help
Services
Are you in trouble with the FDA?
Don’t panic — you’ve got backup. Download 5 Tips to Help You Navigate FDA Enforcement and learn how to resolve the situation now.
Expert knowledge of FDA regulations that helps you strategically grow your business
The Step-by-Step Process to Lifting an Injunction
| 01 |
| Establish Sustained Compliance
Complete required corrective actions and demonstrate sustained compliance throughout the specified period. |
| 02 |
| Document Independent Verification
Obtain required independent audit certifications documenting effective remediation and continued regulatory compliance. |
| 03 |
| Seek Government Non-Opposition
Coordinate with DOJ and FDA counsel to seek non-opposition before requesting dissolution. |
| 04 |
| Obtain Court-Ordered Relief
Petition the federal court for termination, removing restrictions as its order permits. |
Preventing Injunctions Through Early Enforcement Defense
Effective consent decree defense begins before DOJ files a complaint. Responding to FDA Form 483 inspectional observations requires a clear explanation of corrective actions, supporting evidence, and achievable completion dates. Our proactive Warning Letter defense helps businesses address regulatory concerns before enforcement escalates. Legal review strengthens these submissions by ensuring factual accuracy, avoiding unsupported admissions, and aligning commitments with your company’s remediation capabilities.
With more than 16 years of regulatory enforcement experience, FDA Atty helps companies navigate threats to their assets, operations, and commercial future. We work with executives to develop credible responses and prioritize corrective measures that address FDA’s concerns. Our approach supports informed decisions, preserves negotiating opportunities, and helps leadership maintain credibility throughout the enforcement process.
“